54
Participants
Start Date
March 31, 2024
Primary Completion Date
July 31, 2024
Study Completion Date
December 31, 2024
Recombinant type III humanized collagen solution for injection
Each subject will receive one injection of Recombinant type III humanized collagen solution for injection on the whole face
SkinCeuticals recombinant humanized collagen (RHC) serum
Subjects received SkinCeuticals recombinant humanized collagen (RHC) serum application on the test side face
Regular face cream smear
Subjects received Regular face cream smear application on the whole face
DeYi Aesthetic Medical Clinic
OTHER